提供来自世界经济和金融领域的
最新信息
(RTTNews) - Shares of Emergent BioSolutions Inc. (EBS) rose 95 percent on Wednesday after the announcement of appointment of Joseph Papa as the President and Chief Executive Officer of the company, replacing Haywood Miller, effective immediately.
The biotechnology company's stock is currently trading at $2.9689, up 95.85 percent, over the previous close of $1.52 on a volume of 29,450,328.
The stock had traded between $1.42 and $14.39 in the past 52-week period on the New York Stock Exchange.
Previously, Papa served as the Chairman and CEO of Bausch and Lomb Corp. (BLCO).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd 由塞浦路斯证券交易委员会根据2015年9月25日发布的第281/15号许可证授权和监管。“Just2Trade”商标归LimeTrading(CY)有限公司所有。
注册号码: HE 341520
地址: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
免责声明:
本网站上的所有信息和材料未经许可不得使用。更多信息,请联系公司。
在金融市场上交易存在风险。投资产品可能会升值也可能会贬值,投资者可能会损失所有的本金。在涉及有杠杆的产品时,损失可能会大于初始本金。在金融市场上交易的风险信息可以在此查看 全面风险披露。.